CliffBio
small molecule

PINDOLOL

PINDOLOL

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand namePINDOLOL
Active ingredientPINDOLOL
Strength10MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1993
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.